New approach aims to tame dangerous transplant complication
NCT ID NCT05123040
Summary
This study tested a new combination of three drugs to treat a severe and dangerous complication called acute graft-versus-host disease (GVHD) that can happen after a stem cell or bone marrow transplant. The main goal was to find the lowest possible dose of steroids (corticosteroids) that could be used safely alongside two other drugs, hoping to reduce steroid side effects while still controlling the disease. The trial was for patients aged 12 and older who had recently been diagnosed with this high-risk condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE GRAFT VERSUS HOST DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Masonic Cancer Center at University of Minnesota
Minneapolis, Minnesota, 55455, United States
Conditions
Explore the condition pages connected to this study.